Lilly Bamlanivimab Antibody Playbook

This Antibody Playbook provides information for state, territorial and local public health programs.

This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.

Related Content

Why 340B Is Essential for Children's Health

The program makes life-saving drugs more affordable for hospitals that care for our nation’s children.

Oct. 07, 2025

Unlocking Hope with Improved Access to Gene Therapy

The promise of CGTs is tempered by their staggering cost and treatment complexity.

Sep. 23, 2025

How a Health Care Supply Chain Officer Supports Patient Care

Discover insights from a longtime children’s hospital supply chain leader on supporting patient care, community needs, and the health care supply chain.

Sep. 16, 2025